Is TMO up or down today?
TMO is up 2.30% today, last at 698.34. This stock moved +2.30% versus the prior close.
TMO · Thermo Fisher Scientific
TMO (Thermo Fisher Scientific) is trading at 698.34, up 2.30% on the session. TMO sits at the 95% mark of its 52-week range, carries a 14-day RSI of 58, and trades above its 50-day average. Over the past month it is up 3.19%.
Leading the coverage: “Global Human Papillomavirus (HPV) Genotyping Panels Market Report 2026 | Capitalize on NGS, AI and Self-Collection Through 2030 with Roche, Abbott, Thermo Fisher and QIAGEN” (Yahoo, 4d ago). TMO is +3.26% since story.
TMO trades on a trailing P/E of 36.5 and is running 5.83% ahead of the S&P 500 over the same stretch.
Analyst firms are mostly reiterating — no strong directional shift lately.
TMO is up 2.30% today, last at 698.34. This stock moved +2.30% versus the prior close.
Leading the coverage: “Global Human Papillomavirus (HPV) Genotyping Panels Market Report 2026 | Capitalize on NGS, AI and Self-Collection Through 2030 with Roche, Abbott, Thermo Fisher and QIAGEN” (Yahoo, 4d ago). TMO is +3.26% since story. Dominant story: This Insider Has Just Sold Shares In Thermo Fisher Scientific - Simply Wall St (4 sources, bullish) RSI is 58 — leaning bullish Price above 50-day average — short-term uptrend Social sentiment loads separately — see the Social tab.
Analyst firms are mostly reiterating — no strong directional shift lately.
Loaded: May 2026 – Nov 2026 (125 days) · Drag or scroll left for earlier dates
This Insider Has Just Sold Shares In Thermo Fisher Scientific - Simply Wall St
Cell Harvesting - Global Strategic Business Report: Capitalize on 7.6% CAGR to US$516.3 Million by 2030 as Thermo Fisher Scientific, PerkinElmer, Corning and Sartorius Accelerate Automation
Biobanks - Global Strategic Business Report: Capitalize on a US$51.7 Billion Revenue Surge by 2030 as Thermo Fisher Scientific, Merck KGaA, BioLifeSolutions, and Tecan Reshape the Market
Metabolomics - Global Strategic Business Report: Capitalize on an 11.7% CAGR to Secure the $7.1 Billion 2030 Market as Thermo Fisher, Agilent, Bruker, Waters, and Metabolon Reshape Competition
Biopreservation - Global Strategic Business Report: Capitalize on 18.2% CAGR to $10.7 Billion by 2032 as BioLife Solutions, Thermo Fisher Scientific, Qiagen, and Panasonic Reshape the Market